Goldman Sachs Reiterates Buy Rating on Eli Lilly (LLY)

April 28, 2025 6:22 AM EDT Send to a Friend
Goldman Sachs analyst Asad Haider reiterated a Buy rating and $888.00 price target on Eli Lilly (NYSE: LLY).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login